Introduction
In intensive care units (ICUs), 30 to 50 patients out of every 100 receive a red blood cell (RBC) transfusion throughout their hospital stay. Patients typically get five units of red blood cells during their stay in the intensive care unit. These transfusions are primarily necessary for anemia, defined as having insufficient red blood cells or hemoglobin; anemia accounts for 46 to 90 of every 100 cases. About 60 out of every 100 patients have anemia when they initially enter the ICU, and by the eighth day, almost all patients, roughly 97 out of 100, have anemia. People in the intensive care unit (ICU) can develop anemia for a variety of causes, but chronic disease-related issues with iron regulation are the most frequent cause.
In the past, medical professionals decided when to administer blood transfusions based on various guidelines that needed better data support. The "10/30" rule was developed in 1942 by Adams and Lundy. It said a patient should receive a transfusion, particularly if they were a surgical patient whose hematocrit level was below 30 percent or whose hemoglobin level was less than 10 grams per deciliter (g/dL). This regulation persisted for a very long time. However, throughout the past 20 years, scientists have been investigating whether applying more stringent guidelines while administering blood transfusions is preferable.
What Are the Red Blood Cell Transfusion Thresholds in Specific Populations?
-
General Intensive Care: Blood transfusions should only be given when necessary, rather than regularly, according to evidence suggesting that this is frequently a safer method for patients in the intensive care unit (ICU), particularly those with various critical illnesses. Maintaining hemoglobin levels at seven grams per deciliter (g/dL) seems safe, and it may even be preferable to higher levels around 10 g/dL.
-
Sepsis: Research indicates that a lower hemoglobin threshold (about seven g/dL) for blood transfusion is equally safe as a higher threshold (approximately nine g/dL) in severe infection, resulting in septic shock. This method lowers transfusion requirements without compromising survival rates.
-
Acute Coronary Syndrome: There is some disagreement regarding patients who are having acute cardiac issues, such as a heart attack. According to some research, hemoglobin levels should be kept between eight and 10 g/dL. However, maintaining them at eight g/dL may be preferable. Clearer advice will only come after further investigation.
-
Stable Cardiovascular Disease: Compared to people with higher hemoglobin thresholds (about 10 g/dL), people with stable cardiovascular disease (CVD) may also benefit from a lower hemoglobin threshold (around eight g/dL). With the lower threshold, there may be a minor increase in the risk of cardiac issues. For more conclusive advice, more investigation is required.
-
Bleeding in the GI Tract: Maintaining hemoglobin levels at seven g/dL, as opposed to higher levels at nine g/dL, seems to improve survival and reduce complications in cases of significant stomach bleeding.
-
Hematologic Malignancies: It is unclear what hemoglobin level is ideal for transfusion in patients with blood malignancies or those receiving chemotherapy. Lowering the levels to about seven to nine g/dL may help avoid transfusions, but it does not appear to impact survival or other outcomes substantially.
-
Cardiac Surgery: Research on the ideal hemoglobin level for transfusions during cardiac surgery has yielded inconsistent findings. A threshold of about 7.5 g/dL may be considered for heart surgery patients until further study is done.
-
Acute Neurologic Injury: Hemoglobin levels should normally be kept lower (about seven g/dL) for individuals with brain injuries, such as traumatic brain injury, rather than higher (about 10 g/dL). This strategy does not greatly impact recovery or other outcomes.
-
Burns: Hemoglobin levels should ideally be kept lower (around seven g/dL) in severe burns rather than higher (10 g/dL). This method reduces the need for blood transfusions without impairing healing.
-
Hemorrhagic Shock: A "massive transfusion protocol" is frequently used to rapidly replenish lost blood in cases of extreme bleeding, such as trauma-related hemorrhagic shock. There is ongoing discussion on this regimen's precise blood component ratio, which fluctuates based on the clinical situation.
What Are Recent Advances in Blood Transfusions?
-
Advances in Transfusion Practices: New approaches are being developed in addition to continuous research to optimize the utilization of blood transfusions for various patient types. Among these are the use of whole blood transfusions and non-transfusion methods for preventing and treating anemia.
-
Whole Blood Transfusions: During World War I and II, whole blood transfusions were widely utilized. However, in the 1970s, patients began receiving specific blood components, such as cryoprecipitate, plasma, platelets, and red blood cells, instead of whole blood transfusions. Nonetheless, recent medical experiences in the military are prompting physicians to reconsider the use of whole blood in civilian patients, particularly in cases of trauma or extreme bleeding. Already, certain trauma centers in the United States prioritize transfusions with low-titer group O whole blood. There are current trials where patients are randomly assigned to receive either whole blood or specific components; however, most of these studies have focused on historical cases. Patients who received whole blood and other components fared better than those who received only certain components in one study that examined historical cases. Studies have also examined the use of low-titer group O whole blood that has been refrigerated for use in emergency scenarios before patients' arrival at the hospital.
-
Preventing Anemia: Medical treatments in the intensive care unit (ICU) can lead patients to lose significant amounts of blood daily. This can exacerbate their anemia. Doctors are developing blood-saving techniques to stop this, such as limiting the number of times and volume of blood samples drawn. Blood loss in patients on a ventilator has been lessened because of the use of a specialized method for arterial blood sample collection.
-
Alternative Anemia Treatments: Providing patients with extra iron has not been linked to increased infections or other issues. However, it is unclear if this helps them achieve higher hemoglobin levels or lessens their need for blood transfusions when they leave the hospital. Similarly, no evidence administering the hormone erythropoietin to patients increases their odds of survival or decreases their frequency of blood transfusions. Indeed, it may potentially increase their chance of developing blood clots. More research is required to be certain, even if some studies indicate that providing erythropoietin to trauma victims may help them survive. Erythropoietin is currently only advised for individuals with chronic renal disease.
Conclusion
Transfusions of blood are crucial in intensive care units (ICUs) in hospitals for patients with low red blood cell counts, severe bleeding, or difficulty breathing. The best time to administer these transfusions to most ICU patients is becoming increasingly clear. To continuously provide the best care possible to those who are critically sick, must combine this expanding understanding with additional best practices.
